Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers
In this month's "Innovations in Hepatitis Elimination" author interview, Dr. Ward will review key findings from the Coalition's global survey of hepatitis providers and program managers on the impact of COVID-19. We will also hear from some of the survey respondents who will describe their experience in delivering hepatitis services during the pandemic, including the challenges they faced and the mitigation strategies they found effective in maintaining access to care for their patients.
Select a country to see key HBV and HCV related data or check out the data dashboard homepage
The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews, guidelines, and policy documents. In response to identified global research priorities, the evidence based first looked at implementation of hepatitis B birth dose vaccination and global, regional, national, and sub-national action plans.
Donec ullamcorper nulla non metus auctor fringilla. Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet.
Dr. Carlos Varaldo
He demanded access to HCV medications in the public health system of Brazil leading to major discounts
Dr. Petros Katsioloudes
Over 3 years, he involved all stakeholders, especially the patients in Cyprus to receive Ministry approv
Dr. Khaled Kabil
Since 2006, he has managed establishment of HCV treatment centers leading to the treatment of more than
Dr. Madhumita Premkumar
Our team has successfully treated over 55,000 patients with hepatitis C. The Punjab